On June 23, 2016, United Kingdom (UK) voters decided to leave the European Union […]
Celebrated Industry Veteran to Lead Scientific, Medical, and Regulatory Affairs at Biorasi
Miami, FL, Jan 29, […]
Every year, tens of thousands of clinical trials are initiated. Every year, thousands of initiated those trials falter, and, if corrective action isn’t taken, some may fail to produce usable data. In an analysis conducted by the Biorasi research team, we discovered that a full third of trials slated to complete within the next year have already passed their predicted completion date. Given the magnitude of the problem, there is not nearly enough light being shed on this pervasive issue by the industry. In this first white paper in our series, we want to attempt to characterize the scope of the problem facing the drug development industry, and make a case for early, proactive intervention in faltering clinical trials.
Biorasi has a solid track record of experience in dermatology, and our goal for this year […]